Moderna Swings to Q3 Earnings, Revenue Rise; Raises 2026 Revenue Guidance -- Shares Rise Pre-Bell
MT Newswires Live
Yesterday
Moderna (MRNA) reported Q3 earnings Friday of $0.38 per share, swinging from a loss of $0.51 a year earlier.
Analysts polled by FactSet expected a loss of $1.13.
Revenue for the quarter ended Sept. 30 was $1.31 billion, compared with $1.02 billion a year earlier.
Analysts expected $890.3 million.
For 2026, the company now expects revenue growth of 15% to 25%, compared with its prior growth guidance of up to 10%. Analysts are looking for $2.10 billion.
Shares of the company were up 8% in Friday premarket trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.